A detailed history of Everence Capital Management Inc transactions in Insulet Corp stock. As of the latest transaction made, Everence Capital Management Inc holds 2,588 shares of PODD stock, worth $861,027. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,588
Previous 1,660 55.9%
Holding current value
$861,027
Previous $522,000 53.07%
% of portfolio
0.05%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 01, 2025

BUY
$277.3 - $352.82 $257,334 - $327,416
928 Added 55.9%
2,588 $799,000
Q2 2025

Jul 29, 2025

SELL
$238.57 - $327.47 $109,742 - $150,636
-460 Reduced 21.7%
1,660 $522,000
Q1 2025

Apr 22, 2025

BUY
$237.06 - $288.29 $253,654 - $308,470
1,070 Added 101.9%
2,120 $557,000
Q4 2024

Jan 03, 2025

BUY
$227.79 - $275.7 $239,179 - $289,485
1,050 New
1,050 $274,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.